These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35000793)

  • 21. Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions.
    Beghi E; Giussani G; Westenberg E; Allegri R; Garcia-Azorin D; Guekht A; Frontera J; Kivipelto M; Mangialasche F; Mukaetova-Ladinska EB; Prasad K; Chowdhary N; Winkler AS
    J Neurol; 2022 May; 269(5):2265-2274. PubMed ID: 34674005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurological complications of COVID-19: from pathophysiology to rehabilitation. An overview.
    Raciti L; Calabrò RS
    Acta Biomed; 2021 Sep; 92(4):e2021317. PubMed ID: 34487099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal evaluation of neurologic-post acute sequelae SARS-CoV-2 infection symptoms.
    Shanley JE; Valenciano AF; Timmons G; Miner AE; Kakarla V; Rempe T; Yang JH; Gooding A; Norman MA; Banks SJ; Ritter ML; Ellis RJ; Horton L; Graves JS
    Ann Clin Transl Neurol; 2022 Jul; 9(7):995-1010. PubMed ID: 35702954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurological Associations of SARS-CoV-2 Infection: A Systematic Review.
    Javed A
    CNS Neurol Disord Drug Targets; 2022; 21(3):246-258. PubMed ID: 33593267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex and age affect acute and persisting COVID-19 illness.
    Vasilevskaya A; Mushtaque A; Tsang MY; Alwazan B; Herridge M; Cheung AM; Tartaglia MC
    Sci Rep; 2023 Apr; 13(1):6029. PubMed ID: 37055492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological and neuropsychiatric manifestations of post-COVID-19 condition in South America: a systematic review of the literature.
    Gomes LPOZ; Martins CM; Pacheco EC; Avais LS; Borges PKO
    Arq Neuropsiquiatr; 2024 Jan; 82(1):1-8. PubMed ID: 38316427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors.
    Méndez R; Balanzá-Martínez V; Luperdi SC; Estrada I; Latorre A; González-Jiménez P; Feced L; Bouzas L; Yépez K; Ferrando A; Hervás D; Zaldívar E; Reyes S; Berk M; Menéndez R
    J Intern Med; 2021 Sep; 290(3):621-631. PubMed ID: 33533521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
    Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
    Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients.
    Orsini A; Corsi M; Santangelo A; Riva A; Peroni D; Foiadelli T; Savasta S; Striano P
    Neurol Sci; 2020 Sep; 41(9):2353-2366. PubMed ID: 32767055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurological outcomes 1 year after COVID-19 diagnosis: A prospective longitudinal cohort study.
    Rass V; Beer R; Schiefecker AJ; Lindner A; Kofler M; Ianosi BA; Mahlknecht P; Heim B; Peball M; Carbone F; Limmert V; Kindl P; Putnina L; Fava E; Sahanic S; Sonnweber T; Löscher WN; Wanschitz JV; Zamarian L; Djamshidian A; Tancevski I; Weiss G; Bellmann-Weiler R; Kiechl S; Seppi K; Loeffler-Ragg J; Pfausler B; Helbok R
    Eur J Neurol; 2022 Jun; 29(6):1685-1696. PubMed ID: 35239247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Neurological Sequelae Among Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.
    Patel UK; Mehta N; Patel A; Patel N; Ortiz JF; Khurana M; Urhoghide E; Parulekar A; Bhriguvanshi A; Patel N; Mistry AM; Patel R; Arumaithurai K; Shah S
    Cureus; 2022 Sep; 14(9):e29694. PubMed ID: 36321004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal Route: A Nasocerebral Approach against SARS-CoV-2 in NeuroCOVID.
    Baig AM; Gerlach J
    ACS Chem Neurosci; 2023 Oct; 14(19):3560-3563. PubMed ID: 37698524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurological Manifestations of Long COVID: A Single-Center One-Year Experience.
    Taruffi L; Muccioli L; Mitolo M; Ferri L; Descovich C; Mazzoni S; Michelucci R; Lodi R; Liguori R; Cortelli P; Tonon C; Bisulli F
    Neuropsychiatr Dis Treat; 2023; 19():311-319. PubMed ID: 36761395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Complaints and clinical findings six months after COVID-19: outpatient follow-up at the University Medical Center Freiburg].
    August D; Stete K; Hilger H; Götz V; Biever P; Hosp J; Wagner D; Köhler TC; Gerstacker K; Seufert J; Laubner K; Kern W; Rieg S
    Dtsch Med Wochenschr; 2021 Sep; 146(17):e65-e73. PubMed ID: 34425627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Complaints and clinical findings six months after COVID-19: outpatient follow-up at the University Medical Center Freiburg].
    August D; Stete K; Hilger H; Götz V; Biever P; Hosp J; Wagner D; Köhler TC; Gerstacker K; Seufert J; Laubner K; Kern W; Rieg S
    Pneumologie; 2022 Oct; 76(10):679-688. PubMed ID: 36257307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What can the neurological manifestations of COVID-19 tell us: a meta-analysis.
    He Y; Bai X; Zhu T; Huang J; Zhang H
    J Transl Med; 2021 Aug; 19(1):363. PubMed ID: 34425827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.
    Makaronidis J; Firman C; Magee CG; Mok J; Balogun N; Lechner M; Carnemolla A; Batterham RL
    BMC Infect Dis; 2021 Feb; 21(1):221. PubMed ID: 33632171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved.
    Carod-Artal FJ
    Rev Neurol; 2021 Jun; 72(11):384-396. PubMed ID: 34042167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neurological manifestations in patients with severe COVID-19 in a tertiary care center].
    Albarran-Sanchez A; Noyola-García ME; Calderón-Vallejo A; Guízar-García LA; Rosales-Dueñas FJ; Barrientos-Flores CJ; Segura-Mendez NH; Herrera-Sánchez DA; Cuevas-García C
    Rev Med Inst Mex Seguro Soc; 2021 Nov; 59(6):545-550. PubMed ID: 34910416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.